3-Amino-2-chloro-6-(trifluoromethyl)pyridine, 99.0%, 5g

Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate, 95.0%, 250mg

2-[4-(aminomethyl)piperidin-1-yl]nicotinonitrile, 95.0%, 500mg

5-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE, 95%, 500mg

Olmesartan Medoxomil>98.0%(HPLC)(T)1g

2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 5g

2-Methyl-2-butene>95.0%(GC)100mL

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 5 ml, 8000–10000 dalton(s), 12 Piece(s)

1-(3-(Hydroxymethyl)azetidin-1-yl)ethan-1-one, 98%, 1g

3-Bromoimidazo[1,2-a]pyrazine, 95.0%, 25g

Clofentezine>98.0%(HPLC)1g

2-Hydroxy-4-methoxy-benzaldehyde, 98.0%, 100g

2-Morpholino-5-(trifluoromethyl)benzoic acid, 97.0%, 250mg